Daniel Tasse serves as Executive at Bellerophon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Daniel Tasse has executed 8 insider transactions totaling $314.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 31, 2024 involved receiving (via award) 4,790 shares valued at $0.
Daniel Tasse currently holds 11,286 shares of Bellerophon Therapeutics, Inc. (BLPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Tasse has been a net buyer of BLPH stock. They have purchased $314.2K and sold $0 worth of shares.
Daniel Tasse's most recent insider trade was on May 31, 2024, when they sold 4,790 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.83 |
| Discretionary |
| Jun 2, 2023 | RGNX | $0 | Award | 3,486 | $N/A | Discretionary |
| Jun 3, 2022 | RGNX | $0 | Award | 3,010 | $N/A | Discretionary |
| Jun 21, 2018 | BLPH | $0 | Award | 11,987 | $N/A | Discretionary |
| Jun 28, 2017 | BLPH | $0 | Award | 25,363 | $N/A | Discretionary |
| Apr 28, 2016 | BLPH | $0 | Award | 16,356 | $N/A | Discretionary |
| Feb 19, 2015 | BLPH | $300.0K | Purchase | 25,000 | $12.00 | Discretionary |